| Oncogene-induced senescence as an initial barrier in lymphoma development M Braig, S Lee, C Loddenkemper, C Rudolph, AHFM Peters, ... Nature 436 (7051), 660-665, 2005 | 1462 | 2005 |
| A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy CA Schmitt, JS Fridman, M Yang, S Lee, E Baranov, RM Hoffman, ... Cell 109 (3), 335-346, 2002 | 1238 | 2002 |
| Senescence-associated reprogramming promotes cancer stemness M Milanovic, DNY Fan, D Belenki, JHM Däbritz, Z Zhao, Y Yu, JR Dörr, ... Nature 553 (7686), 96-100, 2018 | 864 | 2018 |
| Synthetic lethal metabolic targeting of cellular senescence in cancer therapy JR Dörr, Y Yu, M Milanovic, G Beuster, C Zasada, JHM Däbritz, J Lisec, ... Nature 501 (7467), 421-425, 2013 | 566 | 2013 |
| The dynamic nature of senescence in cancer S Lee, CA Schmitt Nature cell biology 21 (1), 94-101, 2019 | 482 | 2019 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 230 | 2021 |
| Tumor stroma-derived TGF-β limits myc-driven lymphomagenesis via Suv39h1-dependent senescence M Reimann, S Lee, C Loddenkemper, JR Dörr, V Tabor, P Aichele, ... Cancer cell 17 (3), 262-272, 2010 | 211 | 2010 |
| FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf C Bouchard, S Lee, V Paulus-Hock, C Loddenkemper, M Eilers, ... Genes & development 21 (21), 2775-2787, 2007 | 156 | 2007 |
| Targeting the senescence-overriding cooperative activity of structurally unrelated H3K9 demethylases in melanoma Y Yu, K Schleich, B Yue, S Ji, P Lohneis, K Kemper, MR Silvis, N Qutob, ... Cancer cell 33 (2), 322-336. e8, 2018 | 142 | 2018 |
| NF-κB in cellular senescence and cancer treatment H Jing, S Lee Molecules and cells 37 (3), 189-195, 2014 | 129 | 2014 |
| Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations H Jing, J Kase, JR Dörr, M Milanovic, D Lenze, M Grau, G Beuster, S Ji, ... Genes & development 25 (20), 2137-2146, 2011 | 120 | 2011 |
| Chemotherapy response and resistance S Lee, CA Schmitt Current opinion in genetics & development 13 (1), 90-96, 2003 | 97 | 2003 |
| COVID-19 and cellular senescence CA Schmitt, T Tchkonia, LJ Niedernhofer, PD Robbins, JL Kirkland, S Lee Nature Reviews Immunology 23 (4), 251-263, 2023 | 67 | 2023 |
| Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer M Mairhofer, L Kausche, S Kaltenbrunner, R Ghanem, M Stegemann, ... Cancer Cell 39 (9), 1171-1172, 2021 | 50 | 2021 |
| Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence M Kolesnichenko, N Mikuda, UE Höpken, E Kärgel, B Uyar, AB Tufan, ... The EMBO journal 40 (6), e104296, 2021 | 40 | 2021 |
| Epigenetic regulation of histone H3 serine 10 phosphorylation status by HCF-1 proteins in C. elegans and mammalian cells S Lee, V Horn, E Julien, Y Liu, J Wysocka, B Bowerman, MO Hengartner, ... PloS one 2 (11), e1213, 2007 | 34 | 2007 |
| Stabilization but not the transcriptional activity of herpes simplex virus VP16-induced complexes is evolutionarily conserved among HCF family members S Lee, W Herr Journal of Virology 75 (24), 12402-12411, 2001 | 29 | 2001 |
| H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients K Schleich, J Kase, JR Dörr, S Trescher, A Bhattacharya, Y Yu, EM Wailes, ... Nature communications 11 (1), 3651, 2020 | 23 | 2020 |
| The Myc/macrophage tango: oncogene-induced senescence, Myc style S Lee, CA Schmitt, M Reimann Seminars in cancer biology 21 (6), 377-384, 2011 | 17 | 2011 |
| Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma J Du, M Neuenschwander, Y Yu, JHM Däbritz, NR Neuendorff, K Schleich, ... Blood, The Journal of the American Society of Hematology 129 (1), 71-81, 2017 | 12 | 2017 |
